Cargando…

Pathological complete response after preoperative chemotherapy including FOLFOX plus bevacizumab for locally advanced rectal cancer: A case report and literature review

BACKGROUND: In Japan, the significance and efficacy of preoperative chemotherapy alone for locally advanced rectal cancer remain controversial. This case report presents the apparent effectiveness of preoperative FOLFOX plus bevacizumab as shown by pathological complete response (pCR). Additionally,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyamoto, Ryoichi, Kikuchi, Kazunori, Uchida, Atsushi, Ozawa, Masayoshi, Sano, Naoki, Tadano, Sosuke, Inagawa, Satoshi, Oda, Tatsuya, Ohkohchi, Nobuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6726879/ https://www.ncbi.nlm.nih.gov/pubmed/31476559 http://dx.doi.org/10.1016/j.ijscr.2019.08.010

Ejemplares similares

Collision tumor consisting of a colorectal adenocarcinoma and dissemination of a gastric adenocarcinoma
por: Miyamoto, Ryoichi, et al.
Publicado: (2018)

Hepatic sarcoidosis mimicking cholangiocellular carcinoma: A case report and literature review
por: Miyamoto, Ryoichi, et al.
Publicado: (2017)

The impact of three-dimensional reconstruction on laparoscopic-assisted surgery for right-sided colon cancer
por: Miyamoto, Ryoichi, et al.
Publicado: (2017)

Three-dimensional surgical simulation of the bile duct and vascular arrangement in pancreatoduodenectomy: A retrospective cohort study
por: Miyamoto, Ryoichi, et al.
Publicado: (2018)

The Effect of Three-Dimensional Preoperative Simulation on Liver Surgery
por: Nakayama, Ken, et al.
Publicado: (2017)

Gastric adenocarcinoma of fundic gland mucosa type localized in the submucosa: A case report
por: Uchida, Atsushi, et al.
Publicado: (2018)

Three-dimensional reconstruction of vascular arrangement including the hepatic artery and left gastric vein during gastric surgery
por: Miyamoto, Ryoichi, et al.
Publicado: (2016)

Well leg compartment syndrome after surgery for ulcerative colitis in the lithotomy position: A case report
por: Enomoto, Tsuyoshi, et al.
Publicado: (2016)

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
por: Lacombe, Caroline, et al.
Publicado: (2023)

Cediranib with mFOLFOX6 vs bevacizumab with mFOLFOX6 in previously treated metastatic colorectal cancer
por: Cunningham, D, et al.
Publicado: (2013)

Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis
por: Ohara, Yusuke, et al.
Publicado: (2016)

A Case of Appendiceal Adenocarcinoma with Clinical Benefit from FOLFOX and Bevacizumab
por: Powell, Erin D., et al.
Publicado: (2009)

Cost-effectiveness of FOLFOX6+Bevacizumab Versus FOLFOX6+Cetuximab in Stage IV Colorectal Cancer Patients in Shiraz, Iran
por: Jafari, Abdosaleh, et al.
Publicado: (2023)

Successful Treatment of Metastatic Anal Canal Adenocarcinoma with mFOLFOX6 + Bevacizumab
por: Matsunaga, Mototsugu, et al.
Publicado: (2016)

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
por: Wang, Feng, et al.
Publicado: (2022)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)

Atypical Reversible Leucoencephalopathy Syndrome after Bevacizumab/Folfox Regimen for Metastatic Colon Cancer
por: Salmi, Narimane, et al.
Publicado: (2014)

Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report
por: Ohara, Yusuke, et al.
Publicado: (2018)

Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab
por: Otsu, Satoshi, et al.
Publicado: (2014)

MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
por: Kiss, I., et al.
Publicado: (2017)

Gallbladder bleeding associated with microscopic polyangiitis: a case report
por: Kitaguchi, Daichi, et al.
Publicado: (2017)

Pubic osteomyelitis after surgery for perforated colonic diverticulitis with fecal peritonitis: A case report
por: Kitaguchi, Daichi, et al.
Publicado: (2017)

Dualistic role of platelets in living donor liver transplantation: Are they harmful?
por: Liang, Chen, et al.
Publicado: (2022)

Composition of fecal microbiota in low-set rectal cancer patients treated with FOLFOX
por: Li, Jing, et al.
Publicado: (2020)

Pathological Evaluation of Resected Colorectal Liver Metastases: mFOLFOX6 Plus Bevacizumab versus mFOLFOX6 Plus Cetuximab in the Phase II ATOM Trial
por: Takahashi, Takao, et al.
Publicado: (2022)

Phase II study of preoperative bevacizumab, capecitabine and radiotherapy for resectable locally-advanced rectal cancer
por: García, Margarita, et al.
Publicado: (2015)

The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC)
por: Bendell, Johanna C., et al.
Publicado: (2019)

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
por: Lièvre, Astrid, et al.
Publicado: (2009)

Perioperative FOLFOX4 plus bevacizumab for initially unresectable advanced colorectal cancer (NAVIGATE-CRC-01)
por: Suenaga, Mitsukuni, et al.
Publicado: (2015)

Bevacizumab plus FOLFOX or FOLFIRI regimens on patients with unresectable liver-only metastases of metastatic colorectal cancer
por: Mehrzad, Valiollah, et al.
Publicado: (2016)

Overweight is associated with better prognosis in metastatic colorectal cancer patients treated with bevacizumab plus FOLFOX chemotherapy
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2020)

Single-cell analysis reveals cellular reprogramming in advanced colon cancer following FOLFOX-bevacizumab treatment
por: Yang, Meiling, et al.
Publicado: (2023)

A novel hydrogel sheet prevents postoperative pancreatic fistula in a rat model
por: Kemmochi, Akira, et al.
Publicado: (2020)

Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
por: Miyamoto, Ryoichi, et al.
Publicado: (2016)

Randomised phase II trial of mFOLFOX6 plus bevacizumab versus mFOLFOX6 plus cetuximab as first-line treatment for colorectal liver metastasis (ATOM trial)
por: Oki, Eiji, et al.
Publicado: (2019)

Recurrent renal cell carcinoma leading to a misdiagnosis of polycystic liver disease: A case report
por: Liang, Chen, et al.
Publicado: (2019)

A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomy
por: Tamaoki, Yuka, et al.
Publicado: (2015)

DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6
por: O'Connor, J P B, et al.
Publicado: (2011)

Exploring the Potential Role of Rosmarinic Acid in Neuronal Differentiation of Human Amnion Epithelial Cells by Microarray Gene Expression Profiling
por: Ferdousi, Farhana, et al.
Publicado: (2019)

An observational study of extending FOLFOX chemotherapy, lengthening the interval between radiotherapy and surgery, and enhancing pathological complete response rates in rectal cancer patients following preoperative chemoradiotherapy
por: Huang, Chun-Ming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_onri1jpq3s2fcda7ikfnttnlt7